Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Often, yes
Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimers disease: study protocol for a randomised controlled trial (ELAD study)
YL: Writing review & editing, Writing original draft
The WHO recognized two things happening at once: obesity rates are rising globally despite decades of lifestyle-only advice, and newer medications such as GLP-1 drugs consistently produce meaningful weight loss in clinical trials, Jenkinson noted
US$ 28.22
US$ 29.06
US$ 26.68
US$ 24.27
)
